| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.071 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.073 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |